Answers are grounded in this paper and cite their sources.
Granuloma faciale (GF) is an uncommon, benign form of chronic leukocytoclastic vasculitis, which predominantly affects the face and which is notoriously resistant to several therapies. Besides a range of therapeutic modalities, tacrolimus has been recently reported in the successful treatment of GF. Herein we describe the clinical, dermoscopic and histopathological findings in a patient affected by GF and its response to long-term topical treatment with tacrolimus 0.1% cream.
No takes yet. Share an insight, caveat, or question.
Caldarola et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: